Albendazole Veterinary Drug Market Los Angeles, United State,, The global Albendazole Veterinary Drug market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Albendazole Veterinary Drug market. Analysts have used Porters five forces analysis and SWOT analysis to explain the various elements of the market in absolute detail. Furthermore, it also studies the socio-economic factors, political changes, and environmental norms that are likely to affect the global Albendazole Veterinary Drug market.
The research report is committed to giving its readers an unbiased point of view of the global Albendazole Veterinary Drug market. Thus, along with statistics, it includes opinions and recommendation of market experts. This allows the readers to acquire a holistic view of the global market and the segments therein. The research report includes the study of the market segments on the basis of type, application, and region. This helps in identifying segment-specific drivers, restraints, threats, and opportunities.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1702061/covid-19-impact-on-global-albendazole-veterinary-drug-market
The following Companies as the Key Players in the Global Albendazole Veterinary Drug Market Research Report:
, GSK, Sequent Scientific, Zoetis, AdvaCare Pharma, Guangdong Tianbao Biological Pharmaceutical Co., Ltd., Hanzhonghe Times Biotechnology Co., Ltd., Yahui Medicine, Beijing Shengmu Biotechnology Co., Ltd., Hebei Huabang Biological Technology Co., Ltd., Dongguan Meidehao Animal Pharmaceutical Co., Ltd., Sichuan Jinfeng Technology, Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd., Anhui Shenhui Agricultural Technology Co., Ltd., Foshan Zhengdian Biotechnology Co., Ltd., Shanghai Shenya, Tianjin Bijia Pharmaceutical Co., Ltd., Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province, Shimu Group, CSTP, Sneha Medicare Albendazole Veterinary Drug
Albendazole Veterinary Drug Market Product Type Segments
, Capsule Product, Table Product Albendazole Veterinary Drug
Albendazole Veterinary Drug Market Application Segments?<
Swine, Cattle, Others
Regions Covered in the Global Albendazole Veterinary Drug Market:
The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
The scope of the Report:
The research report on the global Albendazole Veterinary Drug market is a comprehensive publication that aims to identify the financial outlook of the market. For the same reason, it offers a detailed understanding of the competitive landscape. It studies some of the leading players, their management styles, their research and development statuses, and their expansion strategies.The report also includes product portfolios and the list of products in the pipeline. It includes a thorough explanation of the cutting-edging technologies and investments being made to upgrade the existing ones.
Enquire for customization in Report @https://www.qyresearch.com/customize-request/form/1702061/covid-19-impact-on-global-albendazole-veterinary-drug-market
Strategic Points Covered in TOC:
1 Study Coverage 1.1 Albendazole Veterinary Drug Product Introduction 1.2 Market Segments 1.3 Key Albendazole Veterinary Drug Manufacturers Covered: Ranking by Revenue 1.4 Market by Type1.4.1 Global Albendazole Veterinary Drug Market Size Growth Rate by Type1.4.2 Capsule Product1.4.3 Table Product 1.5 Market by Application1.5.1 Global Albendazole Veterinary Drug Market Size Growth Rate by Application1.5.2 Swine1.5.3 Cattle1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Albendazole Veterinary Drug Industry Impact1.6.1 How the Covid-19 is Affecting the Albendazole Veterinary Drug Industry
1.6.1.1 Albendazole Veterinary Drug Business Impact Assessment Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and Albendazole Veterinary Drug Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Albendazole Veterinary Drug Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Albendazole Veterinary Drug Market Size Estimates and Forecasts2.1.1 Global Albendazole Veterinary Drug Revenue 2015-20262.1.2 Global Albendazole Veterinary Drug Sales 2015-2026 2.2 Albendazole Veterinary Drug Market Size by Region: 2020 Versus 20262.2.1 Global Albendazole Veterinary Drug Retrospective Market Scenario in Sales by Region: 2015-20202.2.2 Global Albendazole Veterinary Drug Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Albendazole Veterinary Drug Competitor Landscape by Players 3.1 Albendazole Veterinary Drug Sales by Manufacturers3.1.1 Albendazole Veterinary Drug Sales by Manufacturers (2015-2020)3.1.2 Albendazole Veterinary Drug Sales Market Share by Manufacturers (2015-2020) 3.2 Albendazole Veterinary Drug Revenue by Manufacturers3.2.1 Albendazole Veterinary Drug Revenue by Manufacturers (2015-2020)3.2.2 Albendazole Veterinary Drug Revenue Share by Manufacturers (2015-2020)3.2.3 Global Albendazole Veterinary Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)3.2.4 Global Top 10 and Top 5 Companies by Albendazole Veterinary Drug Revenue in 20193.2.5 Global Albendazole Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Albendazole Veterinary Drug Price by Manufacturers 3.4 Albendazole Veterinary Drug Manufacturing Base Distribution, Product Types3.4.1 Albendazole Veterinary Drug Manufacturers Manufacturing Base Distribution, Headquarters3.4.2 Manufacturers Albendazole Veterinary Drug Product Type3.4.3 Date of International Manufacturers Enter into Albendazole Veterinary Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Albendazole Veterinary Drug Market Size by Type (2015-2020)4.1.1 Global Albendazole Veterinary Drug Sales by Type (2015-2020)4.1.2 Global Albendazole Veterinary Drug Revenue by Type (2015-2020)4.1.3 Albendazole Veterinary Drug Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Albendazole Veterinary Drug Market Size Forecast by Type (2021-2026)4.2.1 Global Albendazole Veterinary Drug Sales Forecast by Type (2021-2026)4.2.2 Global Albendazole Veterinary Drug Revenue Forecast by Type (2021-2026)4.2.3 Albendazole Veterinary Drug Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Albendazole Veterinary Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Albendazole Veterinary Drug Market Size by Application (2015-2020)5.1.1 Global Albendazole Veterinary Drug Sales by Application (2015-2020)5.1.2 Global Albendazole Veterinary Drug Revenue by Application (2015-2020)5.1.3 Albendazole Veterinary Drug Price by Application (2015-2020) 5.2 Albendazole Veterinary Drug Market Size Forecast by Application (2021-2026)5.2.1 Global Albendazole Veterinary Drug Sales Forecast by Application (2021-2026)5.2.2 Global Albendazole Veterinary Drug Revenue Forecast by Application (2021-2026)5.2.3 Global Albendazole Veterinary Drug Price Forecast by Application (2021-2026) 6 North America 6.1 North America Albendazole Veterinary Drug by Country6.1.1 North America Albendazole Veterinary Drug Sales by Country6.1.2 North America Albendazole Veterinary Drug Revenue by Country6.1.3 U.S.6.1.4 Canada 6.2 North America Albendazole Veterinary Drug Market Facts & Figures by Type 6.3 North America Albendazole Veterinary Drug Market Facts & Figures by Application 7 Europe 7.1 Europe Albendazole Veterinary Drug by Country7.1.1 Europe Albendazole Veterinary Drug Sales by Country7.1.2 Europe Albendazole Veterinary Drug Revenue by Country7.1.3 Germany7.1.4 France7.1.5 U.K.7.1.6 Italy7.1.7 Russia 7.2 Europe Albendazole Veterinary Drug Market Facts & Figures by Type 7.3 Europe Albendazole Veterinary Drug Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Albendazole Veterinary Drug by Region8.1.1 Asia Pacific Albendazole Veterinary Drug Sales by Region8.1.2 Asia Pacific Albendazole Veterinary Drug Revenue by Region8.1.3 China8.1.4 Japan8.1.5 South Korea8.1.6 India8.1.7 Australia8.1.8 Taiwan8.1.9 Indonesia8.1.10 Thailand8.1.11 Malaysia8.1.12 Philippines8.1.13 Vietnam 8.2 Asia Pacific Albendazole Veterinary Drug Market Facts & Figures by Type 8.3 Asia Pacific Albendazole Veterinary Drug Market Facts & Figures by Application 9 Latin America 9.1 Latin America Albendazole Veterinary Drug by Country9.1.1 Latin America Albendazole Veterinary Drug Sales by Country9.1.2 Latin America Albendazole Veterinary Drug Revenue by Country9.1.3 Mexico9.1.4 Brazil9.1.5 Argentina 9.2 Central & South America Albendazole Veterinary Drug Market Facts & Figures by Type 9.3 Central & South America Albendazole Veterinary Drug Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Albendazole Veterinary Drug by Country10.1.1 Middle East and Africa Albendazole Veterinary Drug Sales by Country10.1.2 Middle East and Africa Albendazole Veterinary Drug Revenue by Country10.1.3 Turkey10.1.4 Saudi Arabia10.1.5 UAE 10.2 Middle East and Africa Albendazole Veterinary Drug Market Facts & Figures by Type 10.3 Middle East and Africa Albendazole Veterinary Drug Market Facts & Figures by Application 11 Company Profiles 11.1 GSK11.1.1 GSK Corporation Information11.1.2 GSK Description, Business Overview and Total Revenue11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)11.1.4 GSK Albendazole Veterinary Drug Products Offered11.1.5 GSK Recent Development 11.2 Sequent Scientific11.2.1 Sequent Scientific Corporation Information11.2.2 Sequent Scientific Description, Business Overview and Total Revenue11.2.3 Sequent Scientific Sales, Revenue and Gross Margin (2015-2020)11.2.4 Sequent Scientific Albendazole Veterinary Drug Products Offered11.2.5 Sequent Scientific Recent Development 11.3 Zoetis11.3.1 Zoetis Corporation Information11.3.2 Zoetis Description, Business Overview and Total Revenue11.3.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)11.3.4 Zoetis Albendazole Veterinary Drug Products Offered11.3.5 Zoetis Recent Development 11.4 AdvaCare Pharma11.4.1 AdvaCare Pharma Corporation Information11.4.2 AdvaCare Pharma Description, Business Overview and Total Revenue11.4.3 AdvaCare Pharma Sales, Revenue and Gross Margin (2015-2020)11.4.4 AdvaCare Pharma Albendazole Veterinary Drug Products Offered11.4.5 AdvaCare Pharma Recent Development 11.5 Guangdong Tianbao Biological Pharmaceutical Co., Ltd.11.5.1 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Corporation Information11.5.2 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Description, Business Overview and Total Revenue11.5.3 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.5.4 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Products Offered11.5.5 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Recent Development 11.6 Hanzhonghe Times Biotechnology Co., Ltd.11.6.1 Hanzhonghe Times Biotechnology Co., Ltd. Corporation Information11.6.2 Hanzhonghe Times Biotechnology Co., Ltd. Description, Business Overview and Total Revenue11.6.3 Hanzhonghe Times Biotechnology Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.6.4 Hanzhonghe Times Biotechnology Co., Ltd. Albendazole Veterinary Drug Products Offered11.6.5 Hanzhonghe Times Biotechnology Co., Ltd. Recent Development 11.7 Yahui Medicine11.7.1 Yahui Medicine Corporation Information11.7.2 Yahui Medicine Description, Business Overview and Total Revenue11.7.3 Yahui Medicine Sales, Revenue and Gross Margin (2015-2020)11.7.4 Yahui Medicine Albendazole Veterinary Drug Products Offered11.7.5 Yahui Medicine Recent Development 11.8 Beijing Shengmu Biotechnology Co., Ltd.11.8.1 Beijing Shengmu Biotechnology Co., Ltd. Corporation Information11.8.2 Beijing Shengmu Biotechnology Co., Ltd. Description, Business Overview and Total Revenue11.8.3 Beijing Shengmu Biotechnology Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.8.4 Beijing Shengmu Biotechnology Co., Ltd. Albendazole Veterinary Drug Products Offered11.8.5 Beijing Shengmu Biotechnology Co., Ltd. Recent Development 11.9 Hebei Huabang Biological Technology Co., Ltd.11.9.1 Hebei Huabang Biological Technology Co., Ltd. Corporation Information11.9.2 Hebei Huabang Biological Technology Co., Ltd. Description, Business Overview and Total Revenue11.9.3 Hebei Huabang Biological Technology Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.9.4 Hebei Huabang Biological Technology Co., Ltd. Albendazole Veterinary Drug Products Offered11.9.5 Hebei Huabang Biological Technology Co., Ltd. Recent Development 11.10 Dongguan Meidehao Animal Pharmaceutical Co., Ltd.11.10.1 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Corporation Information11.10.2 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Description, Business Overview and Total Revenue11.10.3 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.10.4 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Products Offered11.10.5 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Recent Development 11.1 GSK11.1.1 GSK Corporation Information11.1.2 GSK Description, Business Overview and Total Revenue11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)11.1.4 GSK Albendazole Veterinary Drug Products Offered11.1.5 GSK Recent Development 11.12 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd.11.12.1 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Corporation Information11.12.2 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Description, Business Overview and Total Revenue11.12.3 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.12.4 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Products Offered11.12.5 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Recent Development 11.13 Anhui Shenhui Agricultural Technology Co., Ltd.11.13.1 Anhui Shenhui Agricultural Technology Co., Ltd. Corporation Information11.13.2 Anhui Shenhui Agricultural Technology Co., Ltd. Description, Business Overview and Total Revenue11.13.3 Anhui Shenhui Agricultural Technology Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.13.4 Anhui Shenhui Agricultural Technology Co., Ltd. Products Offered11.13.5 Anhui Shenhui Agricultural Technology Co., Ltd. Recent Development 11.14 Foshan Zhengdian Biotechnology Co., Ltd.11.14.1 Foshan Zhengdian Biotechnology Co., Ltd. Corporation Information11.14.2 Foshan Zhengdian Biotechnology Co., Ltd. Description, Business Overview and Total Revenue11.14.3 Foshan Zhengdian Biotechnology Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.14.4 Foshan Zhengdian Biotechnology Co., Ltd. Products Offered11.14.5 Foshan Zhengdian Biotechnology Co., Ltd. Recent Development 11.15 Shanghai Shenya11.15.1 Shanghai Shenya Corporation Information11.15.2 Shanghai Shenya Description, Business Overview and Total Revenue11.15.3 Shanghai Shenya Sales, Revenue and Gross Margin (2015-2020)11.15.4 Shanghai Shenya Products Offered11.15.5 Shanghai Shenya Recent Development 11.16 Tianjin Bijia Pharmaceutical Co., Ltd.11.16.1 Tianjin Bijia Pharmaceutical Co., Ltd. Corporation Information11.16.2 Tianjin Bijia Pharmaceutical Co., Ltd. Description, Business Overview and Total Revenue11.16.3 Tianjin Bijia Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.16.4 Tianjin Bijia Pharmaceutical Co., Ltd. Products Offered11.16.5 Tianjin Bijia Pharmaceutical Co., Ltd. Recent Development 11.17 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province11.17.1 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Corporation Information11.17.2 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Description, Business Overview and Total Revenue11.17.3 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Sales, Revenue and Gross Margin (2015-2020)11.17.4 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Products Offered11.17.5 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Recent Development 11.18 Shimu Group11.18.1 Shimu Group Corporation Information11.18.2 Shimu Group Description, Business Overview and Total Revenue11.18.3 Shimu Group Sales, Revenue and Gross Margin (2015-2020)11.18.4 Shimu Group Products Offered11.18.5 Shimu Group Recent Development 11.19 CSTP11.19.1 CSTP Corporation Information11.19.2 CSTP Description, Business Overview and Total Revenue11.19.3 CSTP Sales, Revenue and Gross Margin (2015-2020)11.19.4 CSTP Products Offered11.19.5 CSTP Recent Development 11.20 Sneha Medicare11.20.1 Sneha Medicare Corporation Information11.20.2 Sneha Medicare Description, Business Overview and Total Revenue11.20.3 Sneha Medicare Sales, Revenue and Gross Margin (2015-2020)11.20.4 Sneha Medicare Products Offered11.20.5 Sneha Medicare Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Albendazole Veterinary Drug Market Estimates and Projections by Region12.1.1 Global Albendazole Veterinary Drug Sales Forecast by Regions 2021-202612.1.2 Global Albendazole Veterinary Drug Revenue Forecast by Regions 2021-2026 12.2 North America Albendazole Veterinary Drug Market Size Forecast (2021-2026)12.2.1 North America: Albendazole Veterinary Drug Sales Forecast (2021-2026)12.2.2 North America: Albendazole Veterinary Drug Revenue Forecast (2021-2026)12.2.3 North America: Albendazole Veterinary Drug Market Size Forecast by Country (2021-2026) 12.3 Europe Albendazole Veterinary Drug Market Size Forecast (2021-2026)12.3.1 Europe: Albendazole Veterinary Drug Sales Forecast (2021-2026)12.3.2 Europe: Albendazole Veterinary Drug Revenue Forecast (2021-2026)12.3.3 Europe: Albendazole Veterinary Drug Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Albendazole Veterinary Drug Market Size Forecast (2021-2026)12.4.1 Asia Pacific: Albendazole Veterinary Drug Sales Forecast (2021-2026)12.4.2 Asia Pacific: Albendazole Veterinary Drug Revenue Forecast (2021-2026)12.4.3 Asia Pacific: Albendazole Veterinary Drug Market Size Forecast by Region (2021-2026) 12.5 Latin America Albendazole Veterinary Drug Market Size Forecast (2021-2026)12.5.1 Latin America: Albendazole Veterinary Drug Sales Forecast (2021-2026)12.5.2 Latin America: Albendazole Veterinary Drug Revenue Forecast (2021-2026)12.5.3 Latin America: Albendazole Veterinary Drug Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Albendazole Veterinary Drug Market Size Forecast (2021-2026)12.6.1 Middle East and Africa: Albendazole Veterinary Drug Sales Forecast (2021-2026)12.6.2 Middle East and Africa: Albendazole Veterinary Drug Revenue Forecast (2021-2026)12.6.3 Middle East and Africa: Albendazole Veterinary Drug Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porters Five Forces Analysis 13.5 Primary Interviews with Key Albendazole Veterinary Drug Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Albendazole Veterinary Drug Customers 14.3 Sales Channels Analysis14.3.1 Sales Channels14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology16.1.1 Methodology/Research Approach16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Yahoo Finance - November 16th, 2024
- Department of Biotechnology Launches Webinar Series on Biomanufacturing and Biofoundry Initiative - IBG NEWS - November 16th, 2024
- Multimodal scanning of genetic variants with base and prime editing - Nature.com - November 16th, 2024
- NEW INITIATIVE BY THE ITALIAN EMBASSY IN WASHINGTON ON BIOTECHNOLOGY WITH THE MILKEN INSTITUTE AND LEADING RESEARCHERS AND INDUSTRY EXPERTS -... - November 16th, 2024
- Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at... - November 16th, 2024
- Albany State offers new Master of Science in Integrated Biotechnology program - The Albany Herald - November 16th, 2024
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Benzinga - November 16th, 2024
- iNtRON Biotechnology (KOSDAQ:048530) Is In A Strong Position To Grow Its Business - Simply Wall St - November 16th, 2024
- PDS Biotechnology Highlights Clinical Progress and Q3 Results - TipRanks - November 16th, 2024
- We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance - November 16th, 2024
- Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St - November 16th, 2024
- APHIS Announces Final Notice on Additional Exemptions for the Movement of Organisms Modified or Produced Through Genetic Engineering - USDA APHIS - November 16th, 2024
- Adaptimmune nears second approval for TCR-T therapy - European Biotechnology News - November 16th, 2024
- Lundbeck reports 18% revenue growth in third quarter - The Pharma Letter - November 16th, 2024
- BioNTech to boost oncology offering with buy of Biotheus - The Pharma Letter - November 16th, 2024
- Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance - November 16th, 2024
- WPI Receives Federal Funding to Address Anticipated Demand for Biology and Biotechnology Professionals and Educators - WPI News - November 3rd, 2024
- Jonathan Dinman to Direct the Institute for Bioscience and Biotechnology Research - College of Computer, Mathematical, and Natural Sciences - November 3rd, 2024
- PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of "Buy" by Analysts - MarketBeat - November 3rd, 2024
- COP16, DSI mechanism for benefit sharing from the use of digital sequence information approved - Renewable Matter - November 3rd, 2024
- Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets - PR Newswire - November 3rd, 2024
- Axonis Therapeutics raises $115 million in Series A financing - The Pharma Letter - November 3rd, 2024
- Regeneron third-quarter 2024 earnings top expectations - The Pharma Letter - November 3rd, 2024
- AbbVie inks up to $1.4 billion deal with EvolveImmune - The Pharma Letter - November 3rd, 2024
- CEO and Chairman of the Executive Board - European Biotechnology News - November 3rd, 2024
- The transformative potential of biotechnology and AI in healthcare - The Armchair Trader - November 3rd, 2024
- U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 - BioSpace - October 6th, 2024
- Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance - October 6th, 2024
- Resolution Therapeutics scores 63.5 million in series B round - The Pharma Letter - October 6th, 2024
- Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist - AOL - October 6th, 2024
- Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research -... - October 6th, 2024
- Sapience Therapeutics Announces Participation at the 4th Annual Needham Private Biotech Company Virtual 1x1 Forum - PR Newswire - October 6th, 2024
- Spyre Therapeutics lures Abivax exec to be its CMO - The Pharma Letter - October 6th, 2024
- Convergence is AIxBio: AI and the Bioeconomy - OODA Loop - October 6th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - ABC News - September 13th, 2024
- Researchers, media engage to educate farmers on biotechnology - University World News - September 13th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - The Associated Press - September 13th, 2024
- Comer Delivers Remarks in Support of Bipartisan BIOSECURE Act - House Committee on Oversight and Reform | - September 13th, 2024
- Announcement of $2 Million for the University of Delaware to Advance Biotechnology - WGMD Radio - September 13th, 2024
- Thailand's Competitiveness Enhanced Through Advanced Biotechnology at Thailand LAB INTERNATIONAL 2024 - BSA bureau - September 13th, 2024
- Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India - BioProcess Insider - September 13th, 2024
- Adam's Biotech Scorecard: Can iTeos and GSK solve TIGIT's troubles? - STAT - September 13th, 2024
- Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to Application with Moffitt Cancer Centre (VIDEO) - DirectorsTalk Interviews - September 13th, 2024
- MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - Business Wire - September 13th, 2024
- MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks - September 13th, 2024
- Viridian Therapeutics reports positive results for veligrotug - The Pharma Letter - September 13th, 2024
- Chinese biotech firms refute US bill, stressing they have no access to Americans personal data - Global Times - September 13th, 2024
- Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments - TipRanks - September 13th, 2024
- Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 13th, 2024
- Time to leverage intellectual property to drive innovation in seed and biotechnology sectors: Experts - The Times of India - May 5th, 2024
- Where Does Capricor Therapeutics Inc (CAPR) Stock Fall in the Biotechnology Field After It Has Risen 24.73% This Week? - InvestorsObserver - March 10th, 2024
- Where Does SpringWorks Therapeutics Inc (SWTX) Stock Fall in the Biotechnology Field After It Has Gained 12.41% This Week? - InvestorsObserver - February 18th, 2024
- Should Biotechnology Stock Axsome Therapeutics Inc (AXSM) Be in Your Portfolio Wednesday? - InvestorsObserver - February 18th, 2024
- Where Does Candel Therapeutics Inc (CADL) Stock Fall in the Biotechnology Field After It Has Gained 22.38% This Week? - InvestorsObserver - February 18th, 2024
- What is Biotechnology? Types and Applications - Iberdrola - January 25th, 2024
- Where Does Immunitybio Inc (IBRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.32% This Week? - InvestorsObserver - January 25th, 2024
- Can Sana Biotechnology Inc (SANA) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver - January 25th, 2024
- Should You Buy Sana Biotechnology Inc (SANA) Stock After it Has Fallen 15.41% in a Week? - InvestorsObserver - January 25th, 2024
- Where Does Tscan Therapeutics Inc (TCRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.81% This Week? - InvestorsObserver - January 25th, 2024
- Should Biotechnology Stock Mink Therapeutics Inc (INKT) Be in Your Portfolio Monday? - InvestorsObserver - May 9th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Has Risen 22.18% This Week? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Dermata Therapeutics Inc (DRMA) Be in Your Portfolio Thursday? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Tempest Therapeutics Inc (TPST) Be in Your Portfolio Wednesday? - InvestorsObserver - May 9th, 2023
- Biotechnology - Applications of biotechnology | Britannica - May 1st, 2023
- Where Does BioLine RX Ltd - ADR (BLRX) Stock Fall in the Biotechnology Field After It Is Down -3.67% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Apellis Pharmaceuticals Inc (APLS) Stock Fall in the Biotechnology Field After It Is Higher By 4.17% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week? - InvestorsObserver - May 1st, 2023
- Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - April 7th, 2023
- Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver - April 7th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? - InvestorsObserver - April 7th, 2023
- Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? - InvestorsObserver - April 7th, 2023
- What is Biotechnology? Definition, Types and Applications | TechTarget - March 21st, 2023
- Where Does Novavax Inc (NVAX) Stock Fall in the Biotechnology Field After It Is Lower By -12.99% This Week? - InvestorsObserver - March 21st, 2023
- Should Biotechnology Stock Outlook Therapeutics Inc (OTLK) Be in Your Portfolio Thursday? - InvestorsObserver - March 21st, 2023
- SANA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - March 21st, 2023
- Where Does Revance Therapeutics Inc (RVNC) Stock Fall in the Biotechnology Field After It Is Lower By -2.17% This Week? - InvestorsObserver - March 5th, 2023
- Is TG Therapeutics Inc common stock (TGTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - March 5th, 2023
- Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Is Down -20.73% This Week? - InvestorsObserver - March 5th, 2023
- Where Does Dyne Therapeutics Inc (DYN) Stock Fall in the Biotechnology Field After It Is Lower By -2.35% This Week? - InvestorsObserver - March 5th, 2023
- Is CytomX Therapeutics Inc (CTMX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 17th, 2022